Feedback / Questions
Undisclosed MAT2A inhibitor - Anagenex
Undisclosed PRMT5 inhibitor - Anagenex
https://www.businesswire.com/news/home/20240717849755/en/Anagenex-Announces-First-Programs-in-Synthetic-Lethal-Oncology-Franchise
 
Jul 17, 2024
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious